Abstract

220 - Cut-Point for Satisfactory Adherence of the Dietary Sodium Restriction Questionnaire for Patients With Heart Failure

Highlights

  • Perceived control in patients with heart failure (HF) is correlated with long-term health outcomes and psychosocial adaptation

  • We evaluated construct validity through associations between Japanese Control Attitudes Scale-Revised (CAS-R), Center for Epidemiologic Studies Depression Scale (CES-D), and State-Trait Anxiety Inventory (STAI) scores, because previous research has found relationships between higher level of perceived control and better mental health outcomes

  • There was a difference in left ventricular ejection fraction (P = .004) and in perceived behavioral control subscale (P = .009)—significantly lower and higher, respectively, in patients admitted for nonadherence

Read more

Summary

Introduction

Evaluation of adherence to ACCF/AHA pharmacologic treatment guidelines for the use of aldosterone antagonist in hospitalized CHF patients at the time of discharge. The current ACCF/ AHA guidelines recommend the use of an aldosterone antagonist in patients with NYHA Class II–IV heart failure and an ejection fraction (EF) of ≤35%, unless contraindicated. Purpose: To evaluate the use of pharmacologic treatment with an aldosterone antagonist in patients with a diagnosis of heart failure (HF) at discharge from an academic medical center. The primary objective was to determine the proportion of patients who received aldosterone antagonist therapy consistent with the ACCF/AHA treatment guideline. Secondary objectives included determining the proportion of patients who received an aldosterone antagonist inconsistent with the guideline and 30- and 90-day readmission rates. Only half of patients admitted with heart failure were discharged on aldosterone antagonist therapy consistent with the ACCF/AHA treatment guideline.

Background
Findings

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.